These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3126543)

  • 1. [Platelet antiaggregants in cardiovascular pathology].
    Merino A; Alegría E; Castelló R; Lorente D; Hidalgo R; Martínez Caro D
    Rev Med Univ Navarra; 1987; 31(4):191-4, 197-202. PubMed ID: 3126543
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet antiaggregants].
    Reverter JC
    Med Clin (Barc); 2000 Jul; 115(6):214-5. PubMed ID: 11002460
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombocyte aggregation inhibitors. A new class of active substances].
    Böhm R; Giessler AJ
    Pharmazie; 1986 Jan; 41(1):1-7. PubMed ID: 3515372
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of antiaggregants in kidney diseases].
    Lapchyns'ka II; Dudar IO
    Lik Sprava; 1993; (10-12):14-20. PubMed ID: 8030297
    [No Abstract]   [Full Text] [Related]  

  • 5. [The anti-platelet aggregation drugs: new approaches based on snake venom polypeptides].
    Marrakchi N; Guermazi S; El Ayeb M
    Arch Inst Pasteur Tunis; 1997; 74(1-2):9-15. PubMed ID: 15945171
    [No Abstract]   [Full Text] [Related]  

  • 6. Controversies in antiplatelet therapy for patients with cardiovascular disease.
    Bates ER; Lau WC
    Circulation; 2005 May; 111(17):e267-71. PubMed ID: 15867186
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecule of the month. Pasugrel.
    Drug News Perspect; 2006 Oct; 19(8):490. PubMed ID: 17160150
    [No Abstract]   [Full Text] [Related]  

  • 8. Terms and conditions: semantic complexity and aspirin resistance.
    Hennekens CH; Schror K; Weisman S; FitzGerald GA
    Circulation; 2004 Sep; 110(12):1706-8. PubMed ID: 15381661
    [No Abstract]   [Full Text] [Related]  

  • 9. An overview of commonly used antiplatelet agents.
    Bungard TJ
    Can J Cardiovasc Nurs; 1998; 9(3):38-46. PubMed ID: 10335141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel.
    Orford JL; Fasseas P; Brosh D; Berger PB
    Indian Heart J; 2001; 53(6):788-91. PubMed ID: 11838939
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet function testing in atherothrombotic disease: steps forward in managing resistance to antiplatelet therapy.
    Grove EL; Hvas AM; Kristensen SD
    Kardiol Pol; 2008 Apr; 66(4):478-9. PubMed ID: 19496276
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors for the prevention and treatment of cardiovascular disease.
    Frishman WH
    Heart Dis; 2000; 2(3):183-4. PubMed ID: 11794142
    [No Abstract]   [Full Text] [Related]  

  • 13. The "clopidogrel resistance" trap.
    Serebruany VL
    Am J Cardiol; 2007 Sep; 100(6):1044-6. PubMed ID: 17826395
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of platelet activation-inhibitory drugs.
    Rao GH; Rao AT
    Indian J Physiol Pharmacol; 1994 Apr; 38(2):69-84. PubMed ID: 8063366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
    Cattaneo M
    Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of action of antiplatelet medication].
    Navarro JL; Frade FJ; Alava I; Obispo T; Trejo R; Jiménez C; Cesar J
    Sangre (Barc); 1984; 29(4-C):817-32. PubMed ID: 6096974
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of garlic on platelet biochemistry and physiology.
    Rahman K
    Mol Nutr Food Res; 2007 Nov; 51(11):1335-44. PubMed ID: 17966136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment.
    Mathewkutty S; McGuire DK
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):541-9. PubMed ID: 19419262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical importance of aspirin resistance].
    Hirmerová J; Filipovský J
    Vnitr Lek; 2004 Jun; 50(6):462-9. PubMed ID: 15346640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.